Regulation of Tumor Cell Motility and Migration by CD63 in a Human Melanoma Cell Line

Journal of Immunology

Volumn 158, Issue 7, 1997, Pages 3353-3358

  Radford, Kristen J ^a   Thorne, Rick F ^b   Hersey, Peter ^a,c  

^a JOHN HUNTER HOSPITAL   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c Oncology and Immunology Unit   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; COLLAGEN; FIBRINOGEN RECEPTOR; FIBRONECTIN; INTEGRIN; LAMININ; LEUKOCYTE ANTIGEN; LYSOSOMAL PROTEIN GP53;

ARTICLE; BIOSYNTHESIS; CELL ADHESION; CELL CULTURE; CELL MOTION; ENZYME SPECIFICITY; HUMAN; IMMUNOLOGY; MELANOMA; METABOLISM; PHYSIOLOGY; SKIN TUMOR;

ANTIGENS, CD; CELL ADHESION; CELL ADHESION MOLECULES; CELL MOVEMENT; COLLAGEN; FIBRONECTINS; HUMANS; INTEGRINS; LAMININ; MELANOMA; PLATELET MEMBRANE GLYCOPROTEINS; SKIN NEOPLASMS; SUBSTRATE SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 0031110226     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Horejsi, V., and C. Vlcek. 1991. Novel structurally distinct family of leukocyte surface glycoproteins including CD9, CD37, CD53 and CD63. FEBS Lett. 288:1.
2. Wright, M. D., and M. G. Tomlinson. 1994. The ins and outs of the transmembrane 4 superfamily. Immunol. Today 15:588.
3. Boucheix, C., P. Benoit, P. Frachet, M. Billard, R. E. Worthington, J. Gagnon, and G. Uzan. 1991. Molecular cloning of the CD9 antigen. J. Biol. Chem. 266: 117.
4. Classon, B. J., A. F. Williams, A. C. Willis, B. Seed, and I. Stamenkovic. 1992. The primary structure of the human leukocyte antigen CD37, a species homologue of the rat MRC OX-44 antigen. J. Exp. Med. 169:1497.
5. Angelisova, P., C. Vlcek, I. Stefanova, M. Lipoldova, and V. Horejsi. 1990. The human leukocyte surface antigen CD53 is a protein structurally similar to the CD37 and MRC OX-44 antigens. Immunogenetics 32:281.
6. Amiot, M. 1990. Identification and analysis of cDNA clones encoding CD53: a pan-leukocyte antigen related to membrane transport proteins. J. Immunol. 145: 4322.
7. Oren, R., S. Takahashi, C. Doss, R. Levy, and S. Levy. 1990. TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins. Mol. Cell. Biol. 10:4007.
8. Gaugitsch, H. W., E. Hofer, N. E. Huber, E. Schnabl, and T. Baumruker. 1991. A new superfamily of lymphoid and melanoma cell proteins with extensive homology to Schistosoma mansoni antigen Sm23. Eur. J. Immunol. 21:377.
9. Gil, M. L., N. Vita, S. Lebel-Binay, B. Miloux, P. Chalon, M. Kaghad, C. Marchiol-Fournigault, H. Conjeaud, D. Caput, P. Ferrara, D. Fradelizi, and A. Quillet-Mary. 1992. A member of the tetra spans transmembrane protein superfamily is recognized by a monoclonal antibody raised against an HLA class I-deficient, lymphokine-activated killer-susceptible. B lymphocyte line. J. Immunol. 148:2826.
10. Yatomi, Y., Y. Ozaki, K. Satoh, and S. Kume. 1993. Anti-CD9 monoclonal antibody elicits staurosporine inhibitable phosphatidylinositol 4,5-bisphosphate hydrolysis, phosphatidylinositol 3,4-bisphosphate synthesis, and protein-tyrosine phosphorylation in human platelets. FEBS Lett. 322:285.
11. Olweus, J., F. Lund-Johansen, and V. Horejsi. 1993. CD53, a protein with four membrane-spanning domains, mediates signal transduction in human monocytes and B cells. J. Immunol. 151:707.
12. Bradbury, L. E., G. S. Kansas, S. Levy, R. L. Evans, and T. F. Tedder. 1992. The CD19/CD21 signal transduction complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J. Immunol. 149: 2841.
13. Lebel-Binay, S., C. Lagaudriere, D. Fradelizi, and H. Conjeaud. 1995. CD82, member of the tetra-span-transmembrane protein family, is a costimulatory protein for T cell activation. J. Immunol. 155:101.
14. Tomlinson, M. G., T. Hanke, D. A. Hughes, A. N. Barclay, E. Scholl, T. Hunig, and M. D. Wright. 1995. Characterization of mouse CD53: epitope mapping, cellular distribution and induction by T cell receptor engagement during repertoire selection. Eur. J. Immunol. 25:2201.
15. Ikeyama, S., M. Koyama, M. Yamaoko, R. Sasada, and M. Miyake. 1993. Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP/CD9) DNA. J. Exp. Med. 177:1231.
16. 1 integrin-dependent motility on fibronectin and laminin substrates and enhanced tyrosine phosphorylation. J. Biol. Chem. 41:24092.
17. Anton, E. S., M. Hadjiargyrou, P. H. Patterson, and W. D. Matthew. 1995. CD9 plays a role in Schwann cell migration in vitro. J. Neurosci. 15:584.
18. Masellis-Smith, A., and A. R. E. Shaw. 1994. CD9-regulated adhesion: anti-CD9 monoclonal antibody induces pre-B cell adhesion to bone marrow fibroblasts through de novo recognition of fibronectin. J. Immunol. 152:2768.
19. Hadjiargyrou, M., and P. H. Patterson. 1995. An anti-CD9 monoclonal antibody promotes adhesion and induces proliferation of Schwann cells in vitro. J. Neurosci. 15:574.
20. Toothill, V. J., J. A. van Mourik, H. K. Niewenhuis, M. J. Metzelaar, and J. D. Pearson. 1990. Characterization of the enhanced adhesion of neutrophil leukocytes to thrombin-stimulated endothelial cells. J. Immunol. 145:283.
21. Angelisova, P., I. Hilgert, and V. Horejsi. 1994. Association of four antigens of the tetraspans family (CD37, CD53, TAPA-1, and R2/C33) with MHC class II glycoproteins. Immunogenetics 39:249.
22. Bell, G. M., W. E. Seaman, E. C. Niemi, and J. B. Imbolden. 1992. The OX-44 molecule couples to signalling pathways and is associated with CD2 on rat T lymphocytes and a natural killer cell line. J. Exp. Med. 175:527.
23. Imai, T., and O. Yoshie. 1993. C33 antigen and M38 antigen recognized by monoclonal antibodies inhibitory to syncytium formation by human T cell leukemia virus type 1 are both members of the transmembrane 4 superfamily and associate with each other and with CD4 or CD8 in T cells. J. Immunol. 151:6470.
24. Iwamoto, R., S. Higashiyama, T. Mitamura, N. Taniguchi, M. Klagsbrun, and E. Mekada. 1994. Heparin-binding EGF-like growth factor, which acts as the diptheria toxin receptor, forms a complex with membrane protein DRAP27/CD9. which up-regulates functional receptors and diptheria toxin sensitivity. EMBO J. 13:2322.
25. Tedder, T. F., L.-J. Zhou, and P. Engel. 1994. The CD19/CD21 signai transduction complex of B lymphocytes. Immunol. Today 15:437.
26. Rubinstein, E., F. Le Naour, M. Billard, M. Prenant, and C. Boucheix. 1994. CD9 antigen is an accessory subunit of the VLA integrin complexes. Eur. J. Immunol. 24:3005.
27. 1 at cell-cell contact sites. J. Cell Biol. 129:1691.
28. Berditchevski, F., G. Bazzoni, and M. E. Hemler. 1995. Specific association of CD63 with Ehe VLA-3 and VLA-6 integrins. J. Biol. Chem. 270:17784.
29. Berditchevski, F., M. M. Zutter, and M. E. Hemler. 1996. Characterization of novel complexes on the cell surface between integrins and proteins with 4 transmembrane domains (TM4 proteins). Mol. Biol. Cell 7:193.
30. 1 integrins in human melanoma. Biochem. Biophys. Res. Commun. 222:13.
31. Atkinson, B., C. S. Ernst, B. F. Christ, A. H. Ross, W. H. Clark, M. Herlyn, D. Herlyn, G. Maul, Z. Steplewski, and H. Koprowski. 1985. Monoclonal antibody to a highly glycosylated prolein reacts in fixed tissue with melanoma and other tumors. Hybridoma 4:243.
32. Hotta, H., A. H. Ross, K. Huebner, M. Isobe, S. Wendeborn, M. V. Chao, R. P. Ricciardi, Y. Tsujimoto, C. M. Croce, and H. Koprowski. 1988. Molecular cloning and characterization of an antigen associated with early stages of melanoma tumor progression. Cancer Res. 48:2955.
33. Kondoh, M., M. Ueda, M. Ichihashi, and Y. Mishima. 1993. Decreased expression of human melanoma-associated antigen ME491 along the progression of melanoma pre-canceroses to invasive and metastatic melanomas. Melanoma Res. 3:241.
34. Nieuwenhuis, H. K., J. J. G. van Oosterhout, E. Rozemuller, F. van Iwaarden, and J. J. Sixma. 1987. Studies with a monoclonal antibody against activated platelets: evidence that a secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation. Blood 70:838.
35. Vischer, U. M., and D. D. Wagner. 1993. CD63 is a component of Weibel-Palade bodies of human endothelial cells. Blood 82:1184.
36. Hotta, H., I. Hara, H. Miyamoto, and M. Homma. 1991. Overexpression of the human melanoma-associated antigen ME491 partially suppresses in vivo malignant phenotypes of H-ras-transformed NIH3T3 cells in athymic nude mice. Melanoma Res. 1:125.
37. Radford, K. J., J. Mallesch, and P. Hersey. 1995. Suppression of human melanoma cell growth and metastasis by the melanoma-associated antigen CD63 (ME491). Int. J. Cancer 62:631.
38. Hynes, R. O. 1992. Integrins: versatility, modulation, and signalling in cell adhesion. Cell 69:11.
39. Juliano, R. L., and S. Haskill. 1993. Signal transduction from the extracellular matrix. J. Cell Biol. 120:577.
40. Hart, I. R., M. Birch, and J. F. Marshall. 1991. Cell adhesion receptor expression during melanoma progression. Cancer Metastasis Rev. 10:115.
41. Edward, M., and R. M. MacKie. 1993. Cell-cell and cell-extracellular matrix interactions during melanoma cell invasion and metastasis. Melanoma Res. 3:227.
42. Edward, M. 1995. Integrins and other adhesion molecules involved in melanocytic tumor progression. Curr. Opin. Oncol. 7:185.
43. Sikora, L. K. J., A. Pinto, D. J. Demetrick, W. T. Dixon, S. J. Urbanski, W. Temple, and L. M. Jerry. 1987. Characterization of a novel neuroglandular antigen (NGA) expressed on abnormal human melanocytes. Int. J. Cancer 39: 138.
44. Akiyama, S. K., S. S. Yamada, W. T. Chen, and K. M. Yamada. 1989. Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization. J. Cell Biol 109:863.
45. Newman, P. J., R. W. Allen, R. A. Kahn, and T. J. Kunicki. 1985. Quantitation of membrane glycoprotein IIIa on intact human platelets using the monoclonal antibody, AP3. Blood 65:227.
46. Yatohgo, T., M. Izumi, H. Kashiwagi, and M. Hayashi. 1988. Novel purification of vitronectin from human plasma by heparin affinity chromatography. Cell Struct. Funct. 13:281.
47. Van Muijen, G. N. P., K. F. J. Jansen, M. H. A. Cornelissen, D. F. C. M. Smeets, J. L. M. Beck, and D. J. Ruiter. 1991. Establishment and characterization of a human melanoma cell line (MV3) which is highly metastatic in nude mice. Int. J. Cancer 48:85.
48. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 277:680.
49. Miyake, M., and S. Hakomori. 1991. A specific cell surface glycoconjugate controlling cell motility: evidence by functional monoclonal antibodies that inhibit cell motility and tumor cell metastasis. Biochemistry 30:3328.
50. Miyake, M., M. Koyama, M. Seno, and S. Ikeyama. 1991. Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motilily. J. Exp. Med. 174:1347.
51. Akiyama, S. K., K. Olden, and K. M. Yamada. 1995. Fibronectin and integrins in invasion and metastasis. Cancer Metastasis Rev. 14:173.
52. Menter, D. G., L. Fitzgerald, J. T. Patton, L. V. Mcintire, and G. L. Nicolson. 1995. Human melanoma integrins contribute to arrest and stabilization potential while flowing over extracellular matrix. Immunol. Cell Biol. 73:575.
53. Hofmann-Wellenhof, R., R. Fink-Puches, J. Smolle, C. Helige, H. A. Tritthart, and H. Keri. 1995. Correlation of melanoma cell motility and invasion in vitro. Melanoma Res. 5:311.
54. 3 subunit with tumor progression. Cancer Res. 50:6757.
55. Cheresh, D. A. 1991. Structure, function and biological properties of integrin alpha v beta 3 on human melanoma cells. Cancer Metastasis Rev. 10:3.
56. Si, Z., and P. Hersey. 1994. Immunohistological examination of the relationship between metastatic potential and expression of adhesion molecules and 'selectins' on melanoma cells. Pathology 26:6.
57. 1 integrin is involved in melanoma cell migration and invasion. Exp. Cell Res. 219:233.
58. 1 heterodimer with tumor progression. Int. J. Cancer 54:68.